Mereo BioPharma (MREO) Return on Invested Capital (2023 - 2024)
Mereo BioPharma (MREO) posted quarterly Return on Invested Capital of 0.03% for Q1 2024, down 57.01% quarter-over-quarter from 0.02% in Q4 2023.
Mereo BioPharma (MREO) Return on Invested Capital (2023 - 2024) Analysis & Trends
Mereo BioPharma (MREO) has reported Return on Invested Capital for 2 consecutive years, with 0.03% the latest figure, recorded in Q1 2024.
- In Q1 2024, Return on Invested Capital changed N/A year-over-year to 0.03%; the TTM figure through Mar 2024 stood at 0.03% (changed N/A YoY), while the FY2022 annual figure was 0.03%, down 2.0% from the prior year.
- Return on Invested Capital slipped to 0.03% in Q1 2024 per MREO's latest filing, from 0.02% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.02% in Q4 2023 and bottomed at 0.03% in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.17% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Mereo BioPharma | 47.39 Mn | 47.39 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -0.03% |
| Dec 31, 2023 | -0.02% |